Corient Capital Partners, LLC Novartis Ag Transaction History

Corient Capital Partners, LLC

  • $1.34 Billion
  • Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,708 shares of NVS stock, worth $750,887. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,708
Previous 5,392 5.86%
Holding current value
$750,887
Previous $455,000 5.93%
% of portfolio
0.04%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $23,576 - $27,574
316 Added 5.86%
5,708 $482,000
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $19,485 - $22,687
-242 Reduced 4.3%
5,392 $455,000
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $115,598 - $130,764
1,443 Added 34.43%
5,634 $494,000
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $544,908 - $602,544
-6,837 Reduced 62.0%
4,191 $366,000
Q3 2021

Nov 16, 2021
BUY
$81.78 - $95.14 $35,328 - $41,100
432 Added 4.08%
11,028 $902,000
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $114,562 - $126,537
1,344 Added 14.53%
10,596 $967,000
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $69,555 - $82,025
833 Added 9.89%
9,252 $791,000
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $249,980 - $302,364
-3,202 Reduced 27.55%
8,419 $795,000
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $18,481 - $20,475
225 Added 1.97%
11,621 $1.01 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $5,422 - $6,103
67 Added 0.59%
11,396 $995,000
Q1 2020

May 06, 2020
SELL
$70.67 - $99.01 $303,668 - $425,445
-4,297 Reduced 27.5%
11,329 $934,000
Q4 2019

Feb 04, 2020
SELL
$84.35 - $95.37 $49,935 - $56,459
-592 Reduced 3.65%
15,626 $1.48 Million
Q3 2019

Nov 06, 2019
SELL
$85.54 - $94.26 $78,782 - $86,813
-921 Reduced 5.37%
16,218 $1.41 Million
Q2 2019

Aug 08, 2019
SELL
$75.4 - $92.8 $32,195 - $39,625
-427 Reduced 2.43%
17,139 $1.57 Million
Q1 2019

May 10, 2019
SELL
$75.32 - $86.15 $40,371 - $46,176
-536 Reduced 2.96%
17,566 $1.69 Million
Q4 2018

Feb 07, 2019
BUY
$73.66 - $82.02 $100,324 - $111,711
1,362 Added 8.14%
18,102 $1.55 Million
Q2 2018

Oct 02, 2018
BUY
$64.91 - $73.36 $133,844 - $151,268
2,062 Added 14.05%
16,740 $1.27 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $285,994 - $341,901
4,063 Added 38.28%
14,678 $1.19 Million
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $56,779 - $60,947
-785 Reduced 6.89%
10,615 $891,000
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $15,421 - $16,072
-208 Reduced 1.79%
11,400 $0
Q2 2017

Aug 14, 2017
BUY
N/A
299 Added 2.64%
11,608 $969,000
Q1 2017

Aug 17, 2017
SELL
N/A
-53,780 Reduced 82.63%
11,309 $840,000
Q1 2017

Aug 14, 2017
BUY
N/A
65,089
65,089 $5.91 Million

Others Institutions Holding NVS

# of Institutions
1,612
Shares Held
136M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email